BRIEF published on 10/22/2024 at 22:50, 1 year 9 months ago DBV's Viaskin Peanut Patch Secures Regulatory Progress in US and EU FDA Approval DBV Technologies Viaskin Peanut Regulatory Update EMA Guidance
PRESS RELEASE published on 10/22/2024 at 22:45, 1 year 9 months ago DBV Announces Positive Regulatory Updates for the Viaskin® Peanut Patch in the United States and Europe DBV Technologies announces positive regulatory updates for Viaskin Peanut Patch in the United States and Europe, aiming for Accelerated Approval for toddlers 1-3 years old Accelerated Approval Regulatory Updates DBV Technologies Viaskin Peanut Patch Toddlers
BRIEF published on 10/18/2024 at 22:35, 1 year 9 months ago DBV Technologies to Engage in ACAAI 2024 Congress DBV Technologies Allergy Treatment Peanut Allergy Viaskin Peanut Patch ACAAI 2024
PRESS RELEASE published on 10/18/2024 at 22:30, 1 year 9 months ago DBV Technologies to Participate in Upcoming ACAAI 2024 Congress DBV Technologies to participate in ACAAI 2024 Congress, presenting on optimal peanut allergy treatment and sponsoring FIT Bowl. Viaskin Peanut patch for food allergies highlighted DBV Technologies Food Allergies Viaskin Peanut Patch ACAAI 2024 Congress Peanut Allergy Treatment
BRIEF published on 10/14/2024 at 22:35, 1 year 9 months ago DBV Technologies Share Capital Status as of September 30, 2024 Share Capital Voting Rights DBV Technologies Euronext Exchanges Listed Shares
BRIEF published on 09/23/2024 at 22:35, 1 year 10 months ago DBV Technologies Completes Screening of Subjects for Phase 3 VITESSE Clinical Trial Clinical Trial Phase 3 DBV Technologies Viaskin Peanut Peanut Allergy
PRESS RELEASE published on 09/23/2024 at 22:30, 1 year 10 months ago DBV Technologies Completes Screening for the VITESSE Phase 3 Clinical Trial DBV Technologies completes screening for VITESSE Phase 3 Clinical Trial evaluating Viaskin Peanut Patch in peanut allergic children ages 4-7. Topline results expected Q4 2025 Clinical Trial DBV Technologies Food Allergies VITESSE Phase 3 Viaskin Peanut Patch
BRIEF published on 09/04/2024 at 22:35, 1 year 10 months ago DBV Technologies to Participate in 26th Annual HC Wainwright Global Investment Conference DBV Technologies Viaskin Food Allergies HC Wainwright Lecture Epicutaneous Immunotherapy
PRESS RELEASE published on 09/04/2024 at 22:30, 1 year 10 months ago DBV Technologies to Participate in the H.C. Wainwright 26th Annual Global Investment Conference DBV Technologies to participate in H.C. Wainwright 26th Annual Global Investment Conference with CEO Daniel Tassé in New York City. Focus on food allergy treatment and immunotherapy Immunotherapy DBV Technologies Food Allergies H.C. Wainwright Conference VIASKIN Patch
BRIEF published on 08/02/2024 at 22:35, 1 year 11 months ago DBV Technologies: Information as of July 31, 2024 on the number of shares and voting rights Share Capital Voting Rights AMF DBV Technologies NYSE Euronext Paris
Published on 07/30/2026 at 13:00, 31 minutes ago Sun Peak Metals Advances Multi-Project Exploration Program in Saudi Arabia - Drill Programs Complete on First Two Projects, Assays Pending
Published on 07/30/2026 at 13:00, 31 minutes ago CoTec Holdings Corp. Investment MagIron Strengthens Leadership Team and Liquidity Position
Published on 07/30/2026 at 13:00, 31 minutes ago Temas and SAGA Successfully Validate RCL Technology With Titanium Recoveries of Up to 90.8% and Vanadium Recoveries of 97.4%
Published on 07/30/2026 at 13:00, 31 minutes ago Electrovaya Launches ElvaPulse(TM) 1500 High-Power Energy Storage Platform for Data Center and Mission-Critical Power Applications
Published on 07/30/2026 at 04:10, 9 hours 21 minutes ago Pathfinder Ventures Announces Appointment of Mark Roseborough as Chief Executive Officer
Published on 07/30/2026 at 13:04, 27 minutes ago Reply S.p.A: The Board of Directors approves the half-year financial report as of 30 June 2026
Published on 07/30/2026 at 12:45, 46 minutes ago H&K AG: Significant growth in revenue, total operating performance and EBITDA; full-year guidance raised
Published on 07/30/2026 at 12:45, 46 minutes ago EQS-Adhoc: H&K AG: Significant growth in revenue, total operating performance and EBITDA; full-year guidance raised
Published on 07/30/2026 at 12:37, 53 minutes ago Zentra Group plc: One Victoria - Contractor Administration and Termination
Published on 07/30/2026 at 09:07, 4 hours 23 minutes ago CNP Assicura, a subsidiary of CNP Assurances in Italy, announces an exclusive partnership with Fineco bank in the life insurance segment
Published on 07/30/2026 at 07:30, 6 hours 1 minute ago Availability of the 2026 Interim Financial Report
Published on 07/30/2026 at 07:30, 6 hours 1 minute ago Half-year 2026: Accor shows its agility in a challenging global environment
Published on 07/30/2026 at 07:00, 6 hours 31 minutes ago Mersen 2026 guidance raised after strong momentum in the first half
